Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization

Platelet function was evaluated before and after clopidogrel therapy in 50 cardiology candidates scheduled for intervention; results were averaged from optical platelet aggregation with 2 significantly correlated point-of-care instruments, Thrombelastograph and Ichor PlateletWorks. Although this was...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2004-02, Vol.93 (4), p.456-458
Hauptverfasser: Mobley, Joseph E., Bresee, Stuart J., Wortham, Dale C., Craft, Robert M., Snider, Carolyn C., Carroll, Roger C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 458
container_issue 4
container_start_page 456
container_title The American journal of cardiology
container_volume 93
creator Mobley, Joseph E.
Bresee, Stuart J.
Wortham, Dale C.
Craft, Robert M.
Snider, Carolyn C.
Carroll, Roger C.
description Platelet function was evaluated before and after clopidogrel therapy in 50 cardiology candidates scheduled for intervention; results were averaged from optical platelet aggregation with 2 significantly correlated point-of-care instruments, Thrombelastograph and Ichor PlateletWorks. Although this was a limited study with few complications, the failure of clopidogrel therapy (30% nonresponders with
doi_str_mv 10.1016/j.amjcard.2003.10.042
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80170622</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914903015790</els_id><sourcerecordid>80170622</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-e149ced228cb13d7aa9016cc8c2d31f3f6529172703831630428437ef1bf00533</originalsourceid><addsrcrecordid>eNqFkUtrFUEQhRsxmGv0JyiDoLu59uPOayUhGA0Esonrpm93Texhpnus7gnEX2-NdyDgxlVRxVfFOXUYeyf4XnBRfx72ZhqsQbeXnCua7flBvmA70TZdKTqhXrId51yWnTh05-x1SgO1QlT1K3ZOo7qrpdyx6Rrh1wLBPhWxL0IMCGmOIUFhQvbzaDKMkAtjs3_0-S9kxzh7Fx8QxsIt6MNDMSNkBJMnCLnoIxarMG8s1fwTMqD_bbKP4Q07682Y4O1WL9iP66_3V9_L27tvN1eXt6U9iDaXQPosOClbexTKNcZ0ZNna1kqnRK_6upKdaGTDVatErch5e1AN9OLYc14pdcE-ne7OGMldynryycI4mgBxSbrlouHkn8AP_4BDXDCQNi0VV1Ujak5QdYIsxpQQej2jnww-acH1GoYe9BaGXsNYxySJ9t5vx5fjBO55a_s-AR83wCRrxh5NsD49c1WjyNjKfTlxQD979IA6WU-ZgfMINmsX_X-k_AHS0atx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230357160</pqid></control><display><type>article</type><title>Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Mobley, Joseph E. ; Bresee, Stuart J. ; Wortham, Dale C. ; Craft, Robert M. ; Snider, Carolyn C. ; Carroll, Roger C.</creator><creatorcontrib>Mobley, Joseph E. ; Bresee, Stuart J. ; Wortham, Dale C. ; Craft, Robert M. ; Snider, Carolyn C. ; Carroll, Roger C.</creatorcontrib><description>Platelet function was evaluated before and after clopidogrel therapy in 50 cardiology candidates scheduled for intervention; results were averaged from optical platelet aggregation with 2 significantly correlated point-of-care instruments, Thrombelastograph and Ichor PlateletWorks. Although this was a limited study with few complications, the failure of clopidogrel therapy (30% nonresponders with &lt;10% average platelet inhibition) was not correlated with clinical pretreatment variables, including atorvastatin therapy, postintervention bleeding complications, or major adverse coronary events.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2003.10.042</identifier><identifier>PMID: 14969622</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Analysis ; Biological and medical sciences ; Blood ; Cardiac Catheterization ; Cardiology. Vascular system ; Cardiovascular disease ; Catheters ; Drug therapy ; Female ; Heart ; Humans ; Male ; Medical sciences ; Medical treatment ; Middle Aged ; Platelet Aggregation Inhibitors - pharmacology ; Platelet Function Tests ; Point-of-Care Systems ; Ticlopidine - analogs &amp; derivatives ; Ticlopidine - pharmacology</subject><ispartof>The American journal of cardiology, 2004-02, Vol.93 (4), p.456-458</ispartof><rights>2004 Excerpta Medica Inc.</rights><rights>2004 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Feb 15, 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-e149ced228cb13d7aa9016cc8c2d31f3f6529172703831630428437ef1bf00533</citedby><cites>FETCH-LOGICAL-c418t-e149ced228cb13d7aa9016cc8c2d31f3f6529172703831630428437ef1bf00533</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.amjcard.2003.10.042$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27925,27926,45996</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15732842$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14969622$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mobley, Joseph E.</creatorcontrib><creatorcontrib>Bresee, Stuart J.</creatorcontrib><creatorcontrib>Wortham, Dale C.</creatorcontrib><creatorcontrib>Craft, Robert M.</creatorcontrib><creatorcontrib>Snider, Carolyn C.</creatorcontrib><creatorcontrib>Carroll, Roger C.</creatorcontrib><title>Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Platelet function was evaluated before and after clopidogrel therapy in 50 cardiology candidates scheduled for intervention; results were averaged from optical platelet aggregation with 2 significantly correlated point-of-care instruments, Thrombelastograph and Ichor PlateletWorks. Although this was a limited study with few complications, the failure of clopidogrel therapy (30% nonresponders with &lt;10% average platelet inhibition) was not correlated with clinical pretreatment variables, including atorvastatin therapy, postintervention bleeding complications, or major adverse coronary events.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis</subject><subject>Biological and medical sciences</subject><subject>Blood</subject><subject>Cardiac Catheterization</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular disease</subject><subject>Catheters</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Heart</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medical treatment</subject><subject>Middle Aged</subject><subject>Platelet Aggregation Inhibitors - pharmacology</subject><subject>Platelet Function Tests</subject><subject>Point-of-Care Systems</subject><subject>Ticlopidine - analogs &amp; derivatives</subject><subject>Ticlopidine - pharmacology</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtrFUEQhRsxmGv0JyiDoLu59uPOayUhGA0Esonrpm93Texhpnus7gnEX2-NdyDgxlVRxVfFOXUYeyf4XnBRfx72ZhqsQbeXnCua7flBvmA70TZdKTqhXrId51yWnTh05-x1SgO1QlT1K3ZOo7qrpdyx6Rrh1wLBPhWxL0IMCGmOIUFhQvbzaDKMkAtjs3_0-S9kxzh7Fx8QxsIt6MNDMSNkBJMnCLnoIxarMG8s1fwTMqD_bbKP4Q07682Y4O1WL9iP66_3V9_L27tvN1eXt6U9iDaXQPosOClbexTKNcZ0ZNna1kqnRK_6upKdaGTDVatErch5e1AN9OLYc14pdcE-ne7OGMldynryycI4mgBxSbrlouHkn8AP_4BDXDCQNi0VV1Ujak5QdYIsxpQQej2jnww-acH1GoYe9BaGXsNYxySJ9t5vx5fjBO55a_s-AR83wCRrxh5NsD49c1WjyNjKfTlxQD979IA6WU-ZgfMINmsX_X-k_AHS0atx</recordid><startdate>20040215</startdate><enddate>20040215</enddate><creator>Mobley, Joseph E.</creator><creator>Bresee, Stuart J.</creator><creator>Wortham, Dale C.</creator><creator>Craft, Robert M.</creator><creator>Snider, Carolyn C.</creator><creator>Carroll, Roger C.</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20040215</creationdate><title>Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization</title><author>Mobley, Joseph E. ; Bresee, Stuart J. ; Wortham, Dale C. ; Craft, Robert M. ; Snider, Carolyn C. ; Carroll, Roger C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-e149ced228cb13d7aa9016cc8c2d31f3f6529172703831630428437ef1bf00533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis</topic><topic>Biological and medical sciences</topic><topic>Blood</topic><topic>Cardiac Catheterization</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular disease</topic><topic>Catheters</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Heart</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medical treatment</topic><topic>Middle Aged</topic><topic>Platelet Aggregation Inhibitors - pharmacology</topic><topic>Platelet Function Tests</topic><topic>Point-of-Care Systems</topic><topic>Ticlopidine - analogs &amp; derivatives</topic><topic>Ticlopidine - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mobley, Joseph E.</creatorcontrib><creatorcontrib>Bresee, Stuart J.</creatorcontrib><creatorcontrib>Wortham, Dale C.</creatorcontrib><creatorcontrib>Craft, Robert M.</creatorcontrib><creatorcontrib>Snider, Carolyn C.</creatorcontrib><creatorcontrib>Carroll, Roger C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mobley, Joseph E.</au><au>Bresee, Stuart J.</au><au>Wortham, Dale C.</au><au>Craft, Robert M.</au><au>Snider, Carolyn C.</au><au>Carroll, Roger C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2004-02-15</date><risdate>2004</risdate><volume>93</volume><issue>4</issue><spage>456</spage><epage>458</epage><pages>456-458</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Platelet function was evaluated before and after clopidogrel therapy in 50 cardiology candidates scheduled for intervention; results were averaged from optical platelet aggregation with 2 significantly correlated point-of-care instruments, Thrombelastograph and Ichor PlateletWorks. Although this was a limited study with few complications, the failure of clopidogrel therapy (30% nonresponders with &lt;10% average platelet inhibition) was not correlated with clinical pretreatment variables, including atorvastatin therapy, postintervention bleeding complications, or major adverse coronary events.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>14969622</pmid><doi>10.1016/j.amjcard.2003.10.042</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2004-02, Vol.93 (4), p.456-458
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_miscellaneous_80170622
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adult
Aged
Aged, 80 and over
Analysis
Biological and medical sciences
Blood
Cardiac Catheterization
Cardiology. Vascular system
Cardiovascular disease
Catheters
Drug therapy
Female
Heart
Humans
Male
Medical sciences
Medical treatment
Middle Aged
Platelet Aggregation Inhibitors - pharmacology
Platelet Function Tests
Point-of-Care Systems
Ticlopidine - analogs & derivatives
Ticlopidine - pharmacology
title Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T14%3A26%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Frequency%20of%20nonresponse%20antiplatelet%20activity%20of%20clopidogrel%20during%20pretreatment%20for%20cardiac%20catheterization&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Mobley,%20Joseph%20E.&rft.date=2004-02-15&rft.volume=93&rft.issue=4&rft.spage=456&rft.epage=458&rft.pages=456-458&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2003.10.042&rft_dat=%3Cproquest_cross%3E80170622%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=230357160&rft_id=info:pmid/14969622&rft_els_id=S0002914903015790&rfr_iscdi=true